Array Biopharma To Present At The Bank Of America Merrill Lynch 2018 Health Care Conference
BOULDER, Colo., May 9, 2018 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Bank of America Merrill Lynch 2018 Health Care Conference in Las Vegas. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
| Event: |
Bank of America Merrill Lynch 2018 Health Care Conference |
| Presenter: |
Ron Squarer, Chief Executive Officer, Array BioPharma |
| Date: |
Wednesday, May 16, 2018 |
| Time: |
8:40 a.m. Pacific Time |
| Webcast: |
http://www.veracast.com/webcasts/baml/healthcare2018/id01202184563.cfm |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other conditions. Ten registration studies are currently advancing related to eight Array-owned or partnered drugs: encorafenib (LGX818), binimetinib (MEK162), ARRY-797, selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Seattle Genetics). For more information on Array, please go to www.arraybiopharma.com.
CONTACT:
Andrea N. Flynn, Ph.D.
Senior Director, Investor Relations & Corporate Communications
(303) 381-6600
[email protected]
SOURCE Array BioPharma
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article